Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: William Partmann who wrote (725)	11/25/1999 2:44:00 PM
From: Gary Korn	Respond to of 10345

I know the following is old news, but it was published down under yesterday: 11/24/99 ABIX (Austl. news abstracts) 24 1999 WL 30163013 ABIX - Australasian Business Intelligence: The Daily Telegraph (Australia) Copyright (C) 1999 Business Intelligence Australia Pty Ltd.; Source: World Reporter (TM) Wednesday, November 24, 1999 Alzheimer's links mice and men On 8 July 1999, researchers at the Ireland-based Elan pharmaceutical firm revealed plans to seek regulatory approval. They will ask the United States Food and Drug Administration for permission to commence a vaccine's clinical safety trials on humans, during 1999. The vaccine - which has been shown to reduce the build-up of plaque in the brains of mice - is seen as providing a potential breakthrough in the fight against Alzheimer's disease. ---- INDEX REFERENCES ---- ORGANIZATION: FOOD_&_DRUG_ADMINISTRATION_USA KEY WORDS: HEALTH & HEALTHCARE; GENERAL NEWS; REGULATION OF BUSINESS; COMPANY NEWS; UNITED STATES OF AMERICA, AMERICASUS; AMERICAS; NORTH AMERICA; PACIFIC RIM NEWS SUBJECT: Health; Public Policy & Regulatory Issues (HLT PBP) INDUSTRY: Biotechnology; Medical & Biological Technology; Drug Manufacturers (BTC MTC DRG) SIC: 2836; 9431; 2834 REGION: United States; North America; Pacific Rim (US NME PRM) Word Count: 73 11/24/99 ABIXANA 24 END OF DOCUMENT

To: William Partmann who wrote (725)	11/26/1999 10:49:00 AM
From: William Partmann	Read Replies (2) \| Respond to of 10345

Insider activity *************************************** ireland.com Friday, November 19, 1999 Market Report -------------------------------------------------------------------------------- By Brendan McGrath, Markets Editor Profit-taking brought the Irish market back from its recent highs, but dealers said it was well underpinned at current levels and further gains were likely before the end of the year - albeit punctuated by occasional bouts of profit-taking. Eircom shares got a good run ahead of yesterday's interim results, which were in line with forecasts. The absence of surprises meant that there was little prospect of the shares consolidating their recent gains and instead they closed 18 cents lower on euro 4.12 (£3.24), after dipping to an early low of euro 4.06. The main factor behind the fall in the index was a sharp fall by CRH, down 62 cents to euro 18.80 (£14.81) and erasing some of the recent gains notched up after the Merrill Lynch "buy" recommendation and the announcement of the National Development Plan. Elan continued to recover after its recent heavy losses and was trading 75 US cents higher at the Irish close on $26.621/2 (euro 25.81). At home, it closed at euro 26.15 (£20.59). Three directors - Mr John Groom, Mr Daniel Tully and Mr Kevin McIntyre - have been recent buyers of the stock at prices between $22.94 and $26.63. Financials were mixed with Bank of Ireland down 15 cents on euro 8.75 (£6.89) although AIB was unchanged on euro 13.70 (£10.79). Irish Life & Permanent, which has lagged the other banks in recent trading, was 10 cents firmer on euro 10.30 (£8.11). Ryanair continued its good run and closed up 10 cents on euro 10.60 (£8.35). Irish stocks on the New York markets were generally firmer although two of the best recent performers, Trintech and Baltimore, were hit by profit-taking. Trintech was trading over $2 lower at the Dublin close on $24.75 (euro 23.99) while Baltimore was $1 lower on $45.25 (euro 43.86). Shares ahead at the Dublin close included Smartforce, Icon and Iona.